P450 inhibitor ketoconazole increased the intratumor drug levels and antitumor activity of fenretinide in human neuroblastoma xenograft models-Reference-Cited by-同舟云学术

P450 inhibitor ketoconazole increased the intratumor drug levels and antitumor activity of fenretinide in human neuroblastoma xenograft models

Published:2017-05-09 Issue:2 Volume:141 Page:405-413
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Lopez-Barcons Lluis¹,Maurer Barry J.²,Kang Min H.³,Reynolds C. Patrick²^ORCID

Affiliation:

1. Cancer Center and Department of Cell Biology and Biochemistry; Texas Tech University Health Sciences Center School of Medicine; Lubbock TX 79430

2. Cancer Center and Departments of Cell Biology and Biochemistry; Pediatrics and Internal Medicine, Texas Tech University Health Sciences Center School of Medicine; Lubbock TX 79430

3. Cancer Center and Departments of Cell Biology and Biochemistry; Internal Medicine, and Pharmacology/Neuroscience, Texas Tech University Health Sciences Center School of Medicine; Lubbock TX 79430

Funder

Cancer Prevention and Research Institute of Texas

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.30706/fullpdf

Reference41 articles.

1. Neuroblastoma (Peripheral neuroblastic tumours);Luksch;Crit Rev Oncol Hematol,2016

2. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group;Matthay;N Engl J Med,1999